1
|
Abdel-Rahman I, Alharbi AA, Alsaedi MZ, Alharbi NMA, Al-Mughassil SB, Al-Bahar ZA, Donkol AR, Baghdadi H, Alanzi ME, El Sayed SM. Significant Promising Effects of Bariatric Surgery on the Biochemical Control of Glycemia and Lipidemia in Diabetic Patients in Western Saudi Arabia: A Tertiary Center Experience and a Retrospective Study. Cureus 2024; 16:e53295. [PMID: 38435872 PMCID: PMC10905210 DOI: 10.7759/cureus.53295] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/24/2024] [Indexed: 03/05/2024] Open
Abstract
BACKGROUND The prevalence of obesity has increased globally and is associated with many comorbidities such as type 2 diabetes and fatty liver and cardiovascular diseases. Bariatric surgery is considered an effective intervention for achieving weight loss and controlling lipidemia and glycemia. OBJECTIVES This Saudi retrospective observational study evaluates the clinical and biochemical benefits following bariatric surgery to obese diabetic patients. Methodology: After gaining ethical committee approval, data was collected from the patients' medical records at a tertiary medical center (King Fahad General Hospital, Al-Madinah Al-Munawwarah, Saudi Arabia). The total sample size was 61 patients, of whom 78.33% (n=48) had a body mass index (BMI) of 40 or greater (obese class III). RESULTS Following bariatric surgery, there were statistically significant reductions (p<0.001) in BMI and HbA1C (decreased from 45.53±7.791 kg/m2 and 7.9±1.82% to 33.42±6.18 kg/m2 and 6.06±1.35%, respectively, after surgery). Likewise, significant reductions (p<0.001) occurred to serum total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides that decreased from 234.4±26.7 mg/dl, 152.2±19.4 mg/dl, and 187.3±24.6 mg/dl to 158.4±17.3 mg/dl, 95.6±15.7 mg/dl, and 132.5±19.5 mg/dl, respectively. Interestingly, serum high-density lipoprotein (HDL) significantly increased (p<0.001) from 43.8±6.2 mg/dl to 52.3±4.6 mg/dl. Using the novel clinical therapeutic index, bariatric surgery decreased BMI by about 26.6%. Using the novel biochemical therapeutic index, bariatric surgery decreased HbA1C, serum total cholesterol, serum LDL cholesterol, and serum triglycerides by about 22.99%, 32.42%, 37.18%, and 29.26%, respectively, while serum HDL increased by about 19.4%. CONCLUSION Bariatric surgery is an effective intervention for obese diabetic patients resulting in weight loss, better control of diabetes and hyperlipidemia, and the metabolic profile. It is also recommended in Saudi Arabia for the high prevalence of obesity and diabetes mellitus.
Collapse
Affiliation(s)
- Ibrahim Abdel-Rahman
- Department of Surgery, Faculty of Medicine, Al-Rayyan Medical Colleges, Al-Madinah Al-Munawwarah, SAU
- Department of General Surgery, Obesity Center, King Fahad General Hospital, Al-Madinah Al-Munawwarah, SAU
| | - Abdulhamid Awadh Alharbi
- Department of General Surgery, Obesity Center, King Fahad General Hospital, Al-Madinah Al-Munawwarah, SAU
| | - Maryam Zain Alsaedi
- College of Medicine, Faculty of Medicine, Al-Rayyan Medical Colleges, Al-Madinah Al-Munawwarah, SAU
| | | | | | - Zainab Anwar Al-Bahar
- College of Medicine, Faculty of Medicine, Al-Rayyan Medical Colleges, Al-Madinah Al-Munawwarah, SAU
| | - Abdel-Raheem Donkol
- Department of General Surgery, Obesity Center, King Fahad General Hospital, Al-Madinah Al-Munawwarah, SAU
- Department of General Surgery, Faculty of Medicine, Aswan University, Aswan, EGY
| | - Hussam Baghdadi
- Department of Clinical Biochemistry and Molecular Medicine, Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, SAU
| | - Mariam Eid Alanzi
- Division of Diabetology, Diabetes Center, Al-Madinah General Hospital, King Salman Bin Abdul-Aziz Medical City, Al-Madinah Health Cluster, Al-Madinah Al-Munawwarah, SAU
| | - Salah Mohamed El Sayed
- Department of Clinical Biochemistry and Molecular Medicine, Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, SAU
- Department of Clinical Biochemistry, Faculty of Medicine, Sohag University, Sohag, EGY
| |
Collapse
|
2
|
El Sayed SM. Al-Hijamah (Prophetic Wet Cupping Therapy) is a Novel Adjuvant Treatment for Viral Hepatitis That Excretes Viral Particles and Excess Ferritin Percutaneously, Synergizes Pharmacotherapy, Enhances Antiviral Immunity and Helps Better HCC Prevention and Treatment: A Novel Evidence-Based Combination with Prophetic Medicine Remedies. J Hepatocell Carcinoma 2023; 10:1527-1546. [PMID: 37727876 PMCID: PMC10505647 DOI: 10.2147/jhc.s409526] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2023] [Accepted: 08/12/2023] [Indexed: 09/21/2023] Open
Abstract
Viral hepatitis progresses to liver cirrhosis and HCC. Several challenges are facing Sovaldi treatment to viral C hepatitis, eg, viral resistance, difficulty to treat all genotypes, and inability to access treatments in low-income countries. Also, current treatments to Hepatitis B are still challenging. Ideal treatments to viral hepatitis should decrease the viral load, enhance antiviral immunity and repair the viruses-induced tissue damage. That is still beyond reach. High serum ferritin in viral hepatitis correlates with chronicity, increased necro-inflammation, hepatotoxicity, progression to cirrhosis, progression to HCC, unresponsiveness to treatments and viremia. Previously, Al-hijamah (wet cupping therapy of prophetic medicine) significantly cleared thalassemic children of causative pathological substances (CPS), eg, excess ferritin, free radicals and serum lipids. Moreover, Al-hijamah significantly increased the antioxidant power and potentiated the natural antiviral immunity, eg, increasing CD4 count, CD8 count and CD4/CD8 ratio. Prophet Muhammad peace be upon him said: "If there is a benenvolence (benefit) in any of your medicines, benefit will be in shrtat mihjam (Al-hijamah), honey drink, and a stinge of fire compatible with disease and I do not like to cauterize". Likewise, the author suggests Al-hijamah as a novel promising adjuvant treatment for viral hepatitis (B and C) for percutaneous excretion of CPS as hepatitis viral particles, excess ferritin, inflammatory mediators, free radicals, and antigen-antibody complexes. Published reports proved that Al-hijamah exerted tissue-protective effects, and cleared blood through the fenestrated skin capillaries in a pressure-dependent and size-dependent manner (a kidney-like manner). That collectively may decrease the viral load for better HCC prevention and supports the evidence-based Taibah theory (Taibah mechanism). Same therapeutic benefits apply to other viral illnesses as AIDS. Even after HCC development, Al-hijamah is quite mandatory for excretion and clearance of CPS that favor malignancy, eg, lactate (Warburg effect), growth factors, metalloproteinases, and others. Al-hijamah-induced immune potentiation benefits HCC patients. Combining Al-hijamah with other natural antioxidant remedies of prophetic medicine, eg, nigella sativa, costus, natural honey, Zamzam water and others will maximize the therapeutic benefits. In conclusion, Al-hijamah and other prophetic medicine remedies are recommended adjuvants to current pharmacological treatments to viral hepatitis and HCC.
Collapse
Affiliation(s)
- Salah Mohamed El Sayed
- Al-Hijamah Clinic, Medical University Center, College of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
- Department of Clinical Biochemistry & Molecular Medicine, Taibah College of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
- Department of Medical Biochemistry, Faculty of Medicine, Sohag University, Sohag, Egypt
- Prophetic Medicine Course & Research, Taibah College of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
| |
Collapse
|
3
|
Mogharbel GH, Badawi AS, Zaman AY, Abd Elmoniem MM, Abdel-Rahman IM, Alenazi ME, Shah FA, Aly MA, Imam SN, Alenazi NE, El Sayed SM. Therapeutic benefits of prophetic medicine remedies in treating hematological diseases (A review article). Am J Blood Res 2023; 13:130-142. [PMID: 37736537 PMCID: PMC10509466] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 11/23/2022] [Accepted: 08/08/2023] [Indexed: 09/23/2023]
Abstract
Hematological disorders are common medical ailments constituting an important cause of morbidity and mortality worldwide, which may be managed efficiently using different prophetic medicine remedies as adjuvants to current therapeutics. Prophetic medicine includes the body of knowledge about medicine that has been derived from the deeds, customs (sunnah), ahadith (sayings), actions, and agreements of Prophet Muhammad, peace be upon him. This review article aims at exploring the magnitude of therapeutic benefits of prophetic medicine remedies as adjuvant treatments to many different types of hematological disorders. Herein, we reviewed many published research studies throughout the literature to delineate the potential therapeutic benefits of prophetic remedies on hematological disorders. Several types of hematological disorders may benefit from prophetic medicine remedies that are rich in natural antioxidants that combat oxidative stress-induced harm e.g. nigella sativa, oral honey, camel milk and urine, Ajwa date fruits, olive oil, Zamzam water and figs. Many prophetic medicine remedies were reported to decrease the hematological cytotoxicity effects induced by different chemicals and are beneficial in treating anemias e.g. iron deficiency anemia, sickle cell anemia, thalassemia, coagulopathies and hematological malignancies as leukemia and myeloma. These remedies treat or alleviate the different hematological disorders using different mechanisms e.g. modulating the immune function, treating deficiencies of different substances, protecting against toxins-induced cytotoxicity, decreasing platelets aggregation, suppressing clotting factors activation, exerting antineoplastic effects (enhancing cancer cells cytotoxicity) and inhibiting angiogenesis. Prophetic medicine remedies exert clinically significant therapeutic benefits for treating COVID-19 pandemic, anemia, thrombosis, thalassemia and blood cancers without inducing toxicity or side effects.
Collapse
Affiliation(s)
- Ghazi H Mogharbel
- Prophetic Medicine Course & Research, Taibah College of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
- Undergraduate Program, Taibah College of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Ahmad S Badawi
- Prophetic Medicine Course & Research, Taibah College of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
- Undergraduate Program, Taibah College of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Amal Yaseen Zaman
- Department of Gynecology and Obstetrics, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | | | | | - Mariam Eid Alenazi
- Consultant of Family Medicine and Diabetes, King Salman Bin Abdel-Aziz Medical City, Ministry of HealthAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Fareed Akbar Shah
- Department of Surgery, Taibah Faculty of Medicine, Taibah UniversityAl-Medinah Al-Munawwarah, Saudi Arabia
| | - Mohamed Abdelnaem Aly
- Department of Surgery, Taibah Faculty of Medicine, Taibah UniversityAl-Medinah Al-Munawwarah, Saudi Arabia
| | - Syed Nazar Imam
- Department of Anatomy, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | | | - Salah Mohamed El Sayed
- Prophetic Medicine Course & Research, Taibah College of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
- Department of Clinical Biochemistry and Molecular Medicine, Taibah College of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
- Department of Medical Biochemistry, Faculty of Medicine, Sohag UniversitySohag, Egypt
| |
Collapse
|
4
|
El Sayed SM. Biochemical Origin of the Warburg Effect in Light of 15 Years of Research Experience: A Novel Evidence-Based View (An Expert Opinion Article). Onco Targets Ther 2023; 16:143-155. [PMID: 36911533 PMCID: PMC9997657 DOI: 10.2147/ott.s397593] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2022] [Accepted: 02/10/2023] [Indexed: 03/07/2023] Open
Abstract
Cancer cells strongly upregulate glucose uptake and glycolysis to produce vital biomolecules for cancer cell survival, proliferation, and metastasis as ATP, lipids, proteins, nucleotides, and lactate. The Warburg effect is tumours' unique glucose oxidation to give lactate (not pyruvate) even in the presence of oxygen. Nicotinamide adenine dinucleotide (NAD/NADH.H) is used in glycolysis via glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and lactate dehydrogenase (LDH). Both catalyse reversible biochemical reactions to produce 1,3-diphosphoglycerate and lactate, respectively. In this expert opinion and based on published evidence, the author suggests that: "In transformed cells and hyperglycolytic cancer cells, the Warburg effect (permanent conversion of pyruvate to lactate) occurs secondary to a vicious cycle and a closed circuit between GAPDH and LDH (reaction of carcinogenesis) causing increased endogenous oxidative stress and subsequent carcinogenesis. Mitochondrial defects in cancer cells cause hyperglycolysis resulting in NADH.H accumulation (produced during GAPDH step) that obligatorily drives LDH to become an irreversible reaction in the direction of lactate formation (Warburg effect) but not pyruvate formation. Likewise, LDH oxidizes NADH.H producing excessive NAD+ that secondarily drives GAPDH reaction to be irreversible to produce NADH.H and so on. Pyruvate is an antioxidant while lactate is pro-oxidant, causing increased endogenous oxidative stress in cancer cells, tumour's hypoxia and obligatory hyperglycolysis with NADH.H overproduction (GAPDH step) to be consumed in the LDH step for lactate production and NAD+ generation (utilized by GAPDH) and so on". This confirms Warburg's origin of cancer cells. Best anticancer applications based on this hypothesis are: breaking this closed vicious circle using siRNA to target GAPDH and LDH, avoiding strong oxidants (as many cancer chemotherapeutics), and using strong antioxidants for causing antioxidant-oxidant antagonism or antioxidant-lactate antagonism to inhibit the Warburg effect. Strong natural antioxidants of prophetic medicine (related to Prophet Muhammad peace be upon him) such as Zamzam water, Nigella sativa, costus, Ajwa date fruit, olive oil, Al-hijamah and natural honey are strongly recommended to prevent and antagonize the Warburg effect.
Collapse
Affiliation(s)
- Salah Mohamed El Sayed
- Department of Clinical Biochemistry & Molecular Medicine, Taibah College of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia.,Department of Medical Biochemistry, Faculty of Medicine, Sohag University, Sohag, Egypt.,Prophetic Medicine Course and Research, Taibah College of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
| |
Collapse
|
5
|
Abdallah AAM, Albadawi EA, Aboonq MS, Desouky MK, Ahmed ARH, Bafail R, Abdel-Halim OB, AbdElmoniem MM, Aldhafiri AJ, Alalawi A, Omran FM, Abdellah WA, Abouelella AMA, El-Sayed AAA, Zaman AY, Almohammadi N, Al Thagfan SS, Abdel-Rahman IM, Alsharif AM, Alanazi ME, El Sayed SM, Baghdadi HH, Abdel-Latif HM. Aleppo galls alleviate paracetamol-induced hepatotoxicity and tissue damage: an experimental study. Int J Biochem Mol Biol 2023; 14:1-9. [PMID: 36936610 PMCID: PMC10018004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 03/28/2022] [Accepted: 11/25/2022] [Indexed: 03/21/2023]
Abstract
BACKGROUND Acute paracetamol toxicity is a common and potentially life-threatening emergency causing liver failure that may necessitate liver transplantation. Unfortunately, current therapies are still defective. OBJECTIVES To investigate the protective effects exerted by Aleppo galls (Quercus infectoria Olivier) extract against acute paracetamol toxicity in mice. METHODOLOGY Eighteen mice were divided into three experimental groups, each included six mice in each group. The groups included: negative control group, paracetamol toxicity group that received an acute toxic intraperitoneal dose of paracetamol (250 mg/kg) for four consecutive days, and treatment group (received 250 mg/kg paracetamol followed few hours later by Aleppo galls extract for the same duration). Animals were anaesthetized using ether anaesthesia. Animals were sacrificed by decapitation and blood samples were drawn. Paracetamol toxicity effects versus Aleppo galls protection were evaluated on liver function tests, liver histology, serum cholesterol and serum triglycerides. RESULTS Acute paracetamol toxicity caused significantly elevated serum transaminases (ALT and AST), decreased serum albumin, and increased serum cholesterol and triglycerides. Aleppo galls extract exerted significant protective effects and restored near normal serum levels of the previously-mentioned parameters. Upon histopathological evaluation, mice in the control group showed normal hepatic architecture with preserved hepatic cords and sinuses. Acute paracetamol toxicity induced peripheral zonal degeneration with focal necrosis of the hepatic tissue. The hepatocytes showed cytoplasmic vacuolation with indistinct cell borders. Central hepatic venules were congested. Administration of Aleppo galls extract reduced the tissue damaging effects induced by paracetamol toxicity with only minimal residual degenerative changes that were observed with absent necrosis. CONCLUSION Quercus infectoria Olivier (Aleppo galls) is a promising source of phytochemicals and future therapeutics.
Collapse
Affiliation(s)
- Ahmed Alamir Mahmoud Abdallah
- Department of Biochemistry, Sohag Faculty of Medicine, Sohag UniversitySohag, Egypt
- Department of Basic Medical Sciences, Aqaba Medical Sciences UniversityAqaba, Jordan
| | - Emad A Albadawi
- Anatomy and Embryology Department, Taibah College of Medicine, Taibah UniversityAl-Madinah, Saudi Arabia
| | - Moutasem Salih Aboonq
- Department of Medical Physiology, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Maha K Desouky
- Anatomy and Embryology Department, Taibah College of Medicine, Taibah UniversityAl-Madinah, Saudi Arabia
- Department of Anatomy, Minia Faculty of Medicine, Minia UniversityMinia, Egypt
| | - Ahmed RH Ahmed
- Department of Pathology, Sohag Faculty of Medicine, Sohag UniversitySohag, Egypt
| | - Rawan Bafail
- Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Osama B Abdel-Halim
- Department of Pharmacognosy and Pharmaceutical Chemistry, College of Pharmacy, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | | | - Ahmed J Aldhafiri
- Department of Pharmacology and Toxicology, College of Pharmacy, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Ali Alalawi
- Department of Pharmacology and Toxicology, College of Pharmacy, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Faten M Omran
- Department of Medical Pharmacology, Sohag Faculty of Medicine, Sohag UniversitySohag, Egypt
| | - Wafaa A Abdellah
- Department of Medical Pharmacology, Sohag Faculty of Medicine, Sohag UniversitySohag, Egypt
| | - Azza MA Abouelella
- Department of Medical Pharmacology, Sohag Faculty of Medicine, Sohag UniversitySohag, Egypt
| | - Abdelaziz AA El-Sayed
- Biology Department, Faculty of Science, Islamic University of Al-MadinahAl-Madinah Al-Munawwarah, Saudi Arabia
- Zoology Department, Faculty of Science, Zagazig UniversityZagazig, Egypt
| | - Amal Yaseen Zaman
- Department of Gynecology and Obstetrics, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Nawal Almohammadi
- Department of Pathology, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Sultan S Al Thagfan
- Department of Clinical and Hospital Pharmacy, College of Pharmacy, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | | | | | - Mariam Eid Alanazi
- Family Medicine & Diabetology Consultant, King Salman Bin Abdul-Aziz Medical City, Ministry of HealthAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Salah Mohamed El Sayed
- Department of Biochemistry, Sohag Faculty of Medicine, Sohag UniversitySohag, Egypt
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Hussam H Baghdadi
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Hytham Mahmoud Abdel-Latif
- Department of Medical Pharmacology, Sohag Faculty of Medicine, Sohag UniversitySohag, Egypt
- Department of Medical Pharmacology, Al-Rayyan Medical CollegesAl-Madinah Al-Munawwarah, Saudi Arabia
| |
Collapse
|
6
|
Abdallah AAM, Bafail R, Zaman AY, Aldhafiri AJ, Alalawi A, Omran FM, Baghdadi HH, Abdellah WA, Alsharif AM, Al Thagfan SS, Abdel-Rahman IM, El-Sawy SA, Abd Elmoniem MM, El Sayed SM, Abdel-Latif HM. Acute paracetamol toxicity-induced inflammatory and oxidative effects are relieved by Aleppo galls: a novel experimental study. Int J Physiol Pathophysiol Pharmacol 2023; 15:1-11. [PMID: 36936543 PMCID: PMC10018072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 03/09/2022] [Accepted: 01/20/2023] [Indexed: 03/21/2023]
Abstract
BACKGROUND Paracetamol (acetaminophen) is an over-the-counter non-steroidal anti-inflammatory drug that may cause acute toxic overdosage particularly in neuropsychiatric patients. Paracetamol is also very commonly prescribed as an analgesic and antipyretic agent. Paracetamol toxicity causes decreased reduced glutathione and oxidative tissue damage. Aleppo galls is a promising natural remedy exerting antioxidant and tissue-protective effects that may combat acetaminophen-induced oxidative tissue damage. METHODOLOGY Biochemical and toxicological effects of a toxic dose of paracetamol (250 mg/kg) were investigated for three consecutive days versus the tissue-protective effects of Aleppo galls. Eighteen white albino mice were randomly allocated in this study and divided into three experimental groups (six mice per group): negative control (received intraperitoneal sterile water injection), paracetamol toxicity group (received intraperitoneal paracetamol injection) and the third group (received paracetamol injection at 250 mg/kg/day together with oral Aleppo galls treatment at 250 mg/kg/day for 3 consecutive days). All mice were sacrificed by the end of the study. RESULTS Our data revealed that paracetamol toxicity exerted significant oxidative stress damaging effects (high serum malondialdehyde, decreased serum catalase and decreased total antioxidant capacity), and significant inflammatory effects (high serum IL-6) and significant tissue-damaging effects (high serum LDH). Aleppo galls treatment significantly protected against acetaminophen toxicity-induced oxidative stress effects (P<0.001), inflammatory effects (P<0.001) and tissue-damaging effects (P<0.001). CONCLUSION Aleppo galls are promising for future drug therapeutics and for the synthesis of natural remedies for treating paracetamol toxicity. We recommend formulating Aleppo galls extract as a pharmaceutical nutrition and to be given to those who need to take large doses of paracetamol.
Collapse
Affiliation(s)
- Ahmed Alamir Mahmoud Abdallah
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversitySohag, Egypt
- Department of Basic Medical Sciences, Aqaba Medical Sciences UniversityAqaba, Jordan
| | - Rawan Bafail
- Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Amal Yaseen Zaman
- Department of Gynecology and Obstetrics, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Ahmed J Aldhafiri
- Department of Pharmacology and Toxicology, College of Pharmacy, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Ali Alalawi
- Department of Pharmacology and Toxicology, College of Pharmacy, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Faten M Omran
- Department of Medical Pharmacology, Sohag Faculty of Medicine, Sohag UniversitySohag, Egypt
| | - Hussam H Baghdadi
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Wafaa A Abdellah
- Department of Medical Pharmacology, Sohag Faculty of Medicine, Sohag UniversitySohag, Egypt
| | | | - Sultan S Al Thagfan
- Department of Clinical and Hospital Pharmacy, College of Pharmacy, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | | | - Samer A El-Sawy
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversitySohag, Egypt
| | | | - Salah Mohamed El Sayed
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversitySohag, Egypt
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Hytham Mahmoud Abdel-Latif
- Department of Medical Pharmacology, Sohag Faculty of Medicine, Sohag UniversitySohag, Egypt
- Department of Medical Pharmacology, Al-Rayyan Medical CollegesAl-Madinah Al-Munawwarah, Saudi Arabia
| |
Collapse
|
7
|
Hussein AH, Jan AA, Alharbi LK, Khalil KA, Abdelrahman AI, El Sayed SM. Rheumatological picture of a patient having multifocal osteonecrosis associated with sickle cell anemia: a case study. Am J Blood Res 2022; 12:156-162. [PMID: 36147607 PMCID: PMC9490107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 03/28/2022] [Accepted: 06/16/2022] [Indexed: 06/16/2023]
Abstract
Avascular necrosis (AVN) is a critical health condition associated with local death of the bone tissue resulting in multifocal osteonecrosis (MFON). After a prior patient's consent, we present a case of sickle cell anemia associated with severe MFON that affected both long bones and short bones. She had a positive history of DVT. Initially, she presented with generalized severe bone pain with fever for seven days that got worse on the day of admission, a picture suggestive of sickle cell anemia-induced vaso-occlusive crisis. She was treated with adequate hydration, morphine, enoxaparin (a low molecular weight heparin), paracetamol and ceftriaxone. She got improved on treatment. On 5th day after admission, she developed sudden severe local tenderness at the distal tibia above the medial malleoli in both legs and she was unable to put a weight on her feet and could not stand up or walk. Plain X-ray films were not diagnostic. Complete liver function tests and kidney function tests were normal. The patient had leukocytosis, high serum urate and high serum LDH (may reflect cellular damage in bone cells). MRI scans revealed an evidence of bilateral multiple avascular necrosis in both femoral heads, left shoulder, left knee, and pelvic bones were evident. The patient's condition was evaluated and the diagnosis of MFON associated with sickle cell crisis was established. This patient responded well to same treatments and her condition got improved. In conclusion, MFON should be considered after vaso-occlusive crisis of sickle cell anemia. Plain X-ray is non-conclusive in diagnosing bony lesions induced by AVN while MRI is diagnostic.
Collapse
Affiliation(s)
- Albader Hamza Hussein
- Rheumatology Department, King Fahd Hospital, Al-Madinah Governorate of HealthAl-Madinah, Saudi Arabia
| | - Abdulhalem A Jan
- Cellular and Molecular Biology Division, Medical Laboratory, King Fahd Hospital, Al-Madinah Governorate of HealthAl-Madinah, Saudi Arabia
| | - Lujain K Alharbi
- Rheumatology Department, King Fahd Hospital, Al-Madinah Governorate of HealthAl-Madinah, Saudi Arabia
| | - Khaled A Khalil
- Rheumatology Department, King Fahd Hospital, Al-Madinah Governorate of HealthAl-Madinah, Saudi Arabia
| | - Abdelrahman I Abdelrahman
- Department of Diagnostic Radiology, Jaber Al Ahmad HospitalKuwait
- Department of Diagnostic Radiology, Zagazig Faculty of Medicine, Zagazig UniversityEgypt
| | - Salah Mohamed El Sayed
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversitySohag, Egypt
| |
Collapse
|
8
|
El-Shanshory M, Hablas NM, El-tahlawi R, Awny S, Aboonq MS, Al Jaouni SK, Abdel-latif TM, Abdel-Gawad AR, Okashah AM, Fakhreldin AR, Baghdadi H, El-Allaf H, Shebel Y, El-Sawy SA, Albeihany A, Mahmoud HS, Sayed AA, Abu-Elnaga MAM, Nabo MMH, El-Dardear A, Abdel-Rahman IM, El Sayed SM, Mahmoud AA. Al-hijamah (the triple S treatment of prophetic medicine) significantly increases CD4/CD8 ratio in thalassemic patients via increasing TAC/MDA ratio: a clinical trial. Am J Blood Res 2022; 12:125-135. [PMID: 36147606 PMCID: PMC9490105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 03/20/2022] [Accepted: 07/13/2022] [Indexed: 06/16/2023]
Abstract
Beta thalassemia is associated with decreased immunity possibly due to iron overload. Al-hijamah (Hijamah) is wet cupping therapy (WCT) of prophetic medicine. Prophet Muhammad Peace be upon him said: "The best among your treatments is Al-hijamah". Al-hijamah is a promising excretory treatment to clear blood of causative pathological substances. Al-hijamah is a three-step technique (skin suction, scarification and suction) i.e. triple S technique). Recently, we introduced Al-hijamah as a novel iron excretion therapy (through pressure-dependent filtration then excretion via the skin dermal capillaries) that significantly decreased serum iron overload and related oxidative stress using a physiological excretory mechanism (Taibah mechanism). Iron overload was reported to impair both humoral immunity and cell mediated immunity in patients with beta thalassemia. In this study, twenty patients having β-thalassemia major (maintained on iron chelation therapy) underwent a single session of Al-hijamah (30-60 minutes) using 4-5 sucking cups only. Another age and sex-matched control group of thalassemic patients received iron chelation therapy only. Al-hijamah enhanced the immunity of thalassemic patients in the form of increased CD4+ T cell count, from 124.10±36.98 to 326.20±57.94 cells/mm3, and an increased CD8+ T cell count from 100.30±36.98 to 272.40±46.37 cells/mm3. CD4/CD8 ratio significantly increased from 1.29 to 1.7 (P<0.001). There was a significant increase of ten times (P<0.001) in serum TAC/MDA ratio (reflects increased antioxidant capacity vs decreased oxidative load and stress) induced by Al-hijamah. After Al-hijamah, both CD4+ and CD8+ T cell counts significantly increased and positively correlated with TAC/MDA ratio (r = 0.246) and (r = 0.190), respectively. Moreover, CD4/CD8 ratio positively correlated with TAC/MDA after Al-hijamah (r = 0.285). In conclusion, Al-hijamah significantly increased CD4/CD8 ratio in thalassemic patients via increasing TAC/MDA ratio. Our study strongly recommends medical practice of Al-hijamah in hospitals for its immune potentiating effects in agreement with the evidence-based Taibah mechanism. Al-hijamah should be generalized for treating other immune-deficiency conditions. Al-hijamah-induced bloody excretion is so minimal and never aggravates the anaemic status.
Collapse
Affiliation(s)
- Mohamed El-Shanshory
- Prophetic Medicine Course and Research, Taibah College of MedicineAl-Madinah Al-Munawwarah, Saudi Arabia
- Department of Paediatrics, Tanta University Faculty of MedicineTanta, Gharbia, Egypt
| | - Nahed Mohammed Hablas
- Department of Paediatrics, Tanta University Faculty of MedicineTanta, Gharbia, Egypt
| | - Rehab El-tahlawi
- Department of Microbiology and Immunology, Zagazig Faculty of Medicine, Zagazig UniversityZagazig, Al-Sharkiyah, Egypt
| | - Shereen Awny
- Department of Internal Medicine, Tanta University Faculty of MedicineTanta, Gharbia, Egypt
| | - Moutasem Salih Aboonq
- Department of Physiology, Taibah College of MedicineAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Soad K Al Jaouni
- YAJ Chair for Prophetic Medicine Applications, King Abdul-Aziz College of MedicineJeddah, Saudi Arabia
| | | | | | - Ahmed M Okashah
- Academic Affairs Director and Consultant Clinical Immunologist, Al-Madinah Directorate of Health, Ministry of HealthAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Ahmed R Fakhreldin
- Department of Paediatrics, Aswan Faculty of Medicine, Aswan UniversityAswan, Egypt
| | - Hussam Baghdadi
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Hassan El-Allaf
- Department of Medical Physiology, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | - Yasmin Shebel
- Department of Paediatrics, Tanta University Faculty of MedicineTanta, Gharbia, Egypt
| | - Samer A El-Sawy
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | - Amal Albeihany
- Department of Haematology, King Faisal Specialist Hospital and Research CenterAl-Madinah Al-Munawwarah, Saudi Arabia
| | | | - Anwar A Sayed
- Department of Medical Microbiology and Immunology, College of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Mostafa AM Abu-Elnaga
- Department of Anatomy and Embryology, College of Medicine, Al-Rayyan CollegesAl-Madinah Al-Munwwarah, Saudia Arabia
- Department of Anatomy and Embryology, College of Medicine, New Damietta, Al-Azhar UniversityEgypt
| | - Manal Mohamed Helmy Nabo
- Paediatrics Department, Al-Rayyan Medical CollegesAl-Madinah Al-Munawwarah, Saudi Arabia
- Division of Paediatric Cardiology, Paediatrics Department, Sohag Teaching Hospital, Ministry of HealthSohag, Egypt
| | - Amr El-Dardear
- Prophetic Medicine Course and Research, Taibah College of MedicineAl-Madinah Al-Munawwarah, Saudi Arabia
- Paediatrics Department, Al-Rayyan Medical CollegesAl-Madinah Al-Munawwarah, Saudi Arabia
| | | | - Salah Mohamed El Sayed
- Prophetic Medicine Course and Research, Taibah College of MedicineAl-Madinah Al-Munawwarah, Saudi Arabia
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | - Ahmed Alamir Mahmoud
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversityEgypt
| |
Collapse
|
9
|
Hassan SMA, Aboonq MS, Albadawi EA, Aljehani Y, Abdel-Latif HM, Mariah RA, Shafik NM, Soliman TM, Abdel-Gawad AR, Omran FM, Abdellah WA, Shehata A, Shahada H, Baghdadi HH, Aly HY, Saad A, Nabo MMH, Almilaibary A, Eltahir HM, El Sayed SM, Abu-Elnaga MAM, Elbastawisy YM. The Preventive and Therapeutic Effects of Ajwa Date Fruit Extract Against Acute Diclofenac Toxicity-Induced Colopathy: An Experimental Study. Drug Des Devel Ther 2022; 16:2601-2616. [PMID: 35965961 PMCID: PMC9366708 DOI: 10.2147/dddt.s344247] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2021] [Accepted: 05/13/2022] [Indexed: 11/23/2022] Open
Abstract
Background Studies regarding treatment of acute toxicity with diclofenac (ATD) are quite few. Diclofenac is commonly prescribed in neurology, psychiatry, and general medicine practice. This study investigated possible colon-protective effects exerted by Ajwa date fruit extract (ADFE), a prophetic medicine remedy native to Al-Madinah, Saudi Arabia against ATD. Phytochemicals in ADFE as gallic acid and quercetin have reported protective effects against ATD. Methods Total phenols and flavonoids in ADFE were estimated as equivalents to gallic acid and quercetin. Four experimental groups were allocated each of six rats: control group, ATD group received a single dose of 150 mg diclofenac intraperitoneally, toxicity prevention group received a single dose of ADFE orally followed 4 hours later by diclofenac injection, and toxicity treatment group received a similar diclofenac dose followed 4 hours later by a single dose of ADFE. Four days later, animals were sacrificed. Histological and biochemical examinations were done. Results ADFE has a total phenolic content of 331.7 gallic acid equivalent/gram extract and a total flavonoid content of 70.23 quercetin equivalent/gram. ATD significantly increased oxidative stress markers as serum malondialdehyde (MDA) and hydrogen peroxide (H2O2). Serum MDA and H2O2 were significantly scavenged by ADFE. ATD significantly (p<0.001) decreased antioxidant power as serum total antioxidant capacity and catalase activity. That was reversed by ADFE in both prevention and treatment groups. Histologically, ATD caused complete destruction of colonic crypts architecture, patchy loss of the crypts, loss of the surface epithelium, absent goblet cells and submucosal exudate, heavy infiltration of the lamina propria and submucosa with inflammatory cells, mainly lymphocytes and eosinophils. There were mucosal haemorrhages and submucosal dilated congested blood vessels. All that was prevented and treated using ADFE. Conclusion ADFE is rich in quercetin and gallic acid equivalents that exert potent antitoxic effects. ADFE is strongly recommended for preventive and therapeutic colon effects against ATD.
Collapse
Affiliation(s)
| | - Moutasem Salih Aboonq
- Department of Medical Physiology, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
| | - Emad A Albadawi
- Anatomy and Embryology Department, Taibah College of Medicine, Taibah University, Al-Madinah, Saudi Arabia
| | - Yasmeen Aljehani
- Academic Affairs, Training and Research (CAO), King Salman Bin Abdelaziz Medical City, Al-Madinah Al-Munawwarah, Saudi Arabia
- Family Medicine, Research and Studies Department and Health Affairs in Al-Madinah Region, Al-Madinah Al-Munawwarah, Saudi Arabia
| | | | - Reham A Mariah
- Department of Medical Biochemistry, Tanta Faculty of Medicine, Tanta University, Tanta, Egypt
| | - Noha M Shafik
- Department of Medical Biochemistry, Tanta Faculty of Medicine, Tanta University, Tanta, Egypt
| | - Tamer M Soliman
- Department of Clinical Pathology, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt
| | | | - Faten M Omran
- Department of Medical Pharmacology, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt
| | - Wafaa A Abdellah
- Department of Medical Pharmacology, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt
| | - Ahmed Shehata
- Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt
| | - Husam Shahada
- Department of Pharmaceutical Care, Uhud Hospital, Al-Madinah, Saudi Arabia
| | - Hussam H Baghdadi
- Department of Clinical Biochemistry, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
| | - Hanan Yousef Aly
- Department of Neuropsychiatry, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt
| | - Alfarazdeg Saad
- Department of Clinical Biochemistry, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
- Correspondence: Alfarazdeg Saad, Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia, Tel +249-91-219-0492, Email
| | | | - Abdullah Almilaibary
- Family and Community Medicine Department, Faculty of Medicine, Albaha University, Albaha, Saudi Arabia
| | - Heba M Eltahir
- Department of pharmacology and toxicology, Biochemistry Division, Taibah University, Medina, Saudi Arabia
| | - Salah Mohamed El Sayed
- Department of Clinical Biochemistry, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt
| | - Mustafa A M Abu-Elnaga
- Department of Anatomy, College of Medicine, Al-Rayyan Medical Colleges, Al-Madinah, Saudi Arabia
- Department of Anatomy, Faculty of Medicine, Al-Azhar University, Damietta, Egypt
| | - Yasser M Elbastawisy
- Anatomy and Embryology Department, Taibah College of Medicine, Taibah University, Al-Madinah, Saudi Arabia
- Anatomy & Embryology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
| |
Collapse
|
10
|
Abu-Dief AM, El-khatib RM, Sayed SME, Alzahrani S, Alkhatib F, El-Sarrag G, Ismael M. Tailoring, structural elucidation, DFT calculation, DNA interaction and pharmaceutical applications of some aryl hydrazone Mn(II), Cu(II) and Fe(III) complexes. J Mol Struct 2021. [DOI: 10.1016/j.molstruc.2021.131017] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
11
|
Mahmoud HS, Eltahlawi RA, Jan AA, Alhadramy O, Soliman TM, El Sayed SM, Abdallah HI, El-shazley M, Shafik NM, Mariah RA, El-Dabie N, Abdel-Haleem M, Hassan SMA, Nabo MMH, El-Alaf H, Baghdadi H, Yousef RS, Mahmoud AA, El Sayed SM, Amer SM. Zamzam water is pathogen-free, uricosuric, hypolipidemic and exerts tissue-protective effects: relieving BBC concerns. Am J Blood Res 2020; 10:386-396. [PMID: 33489448 PMCID: PMC7811908] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 06/28/2020] [Accepted: 10/26/2020] [Indexed: 06/12/2023]
Abstract
Zamzam water is the most frequently used drinking water by millions of people in Saudi Arabia. It is carried all the time by millions of pilgrims to their home countries as gifts to close and near relatives and friends. Safety of constituents of Zamzam water is a vital health topic. British Broadcasting Corporation (BBC) raised many health concerns regarding the high serum arsenic and nitrate contents in Zamzam water that may cause cancer. It is role of scientific research to present scientific facts to relieve such concerns. Arsenic is a carcinogen while nitrate causes methemogloinemia that affect oxygen carriage by haemoglobin. An ethical committee approval was obtained. Eighteen white albino mice (40-45 g) were used in this study. Three experimental groups were allocated (six mice per group): tap water group, distilled water group and Zamzam water group. Our data revealed that Zamzam water exerts tissue-protective effects that contradict malignancy. Our data proved that Zamzam water is pathogen-free causing no bacterial growth on CLED agar colonies. Zamzam water consumption for three consecutive months in mice was quite safe for the general health and significantly decreased serum uric acid (p < 0.05) (possibly due to Zamzam-induced urine alkalinisation facilitating uric acid excretion). Regular Zamzam water consumption significantly decreased serum cholesterol (p < 0.05) and serum triglycerides (p < 0.05). Hypolipidemic effects of Zamzam water may be due to its high mineral content facilitating increased lipids metabolism. Our data confirmed safety of prolonged use of Zamzam water comparable to other drinking water types regarding the metabolic and synthetic functions of the liver. Nitrates in Zamzam water are thought to be an original constituent that may be useful (exerting vasodilation, antithrombotic, and immunoregulatory effects) and not harmless. This may occur due to high Zamzam content of calcium, magnesium and selenium. Histologically, our data confirmed that Zamzam water was quite safe to renal parenchyma and comparable to other types of drinking water. In conclusion, health concerns raised by BBC regarding Zamzam water safety were a good chance for fruitful scientific research investigations that confirmed safety and beneficial effects of Zamzam water for human health.
Collapse
Affiliation(s)
- Hany Salah Mahmoud
- Prophetic Medicine Course and Research, Taibah College of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
- Center of Scientific Foundation for Experimental Studies and ResearchIsmailia, Egypt
| | - Rehab A Eltahlawi
- Department of Microbiology and Immunology, Faculty of Medicine, Zagazig UniversityZagazig, Egypt
- Department of Microbiology and Immunology, Taibah College of Medicine, Taibah UniversitySaudi Arabia
| | - Abdulhalem Abdulsamad Jan
- Laboratory and Blood Bank General Director, King Fahad HospitalAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Osama Alhadramy
- Division of Cardiology, Department of Medicine, Taibah College of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Tamer M Soliman
- Department of Clinical Pathology, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | - Sayed Mostafa El Sayed
- Anatomy and Embryology Department, Faculty of Medicine, Taibah UniversitySaudi Arabia
- Anatomy and Embryology Department, Faculty of Medicine-Ain Shams UniversityEgypt
| | - Hesham I Abdallah
- Anatomy and Embryology Department, Faculty of Medicine, Taibah UniversitySaudi Arabia
- Anatomy and Embryology Department, Faculty of Medicine-Ain Shams UniversityEgypt
| | - Momen El-shazley
- Department of Medicine, Taibah College of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
- Department of Occupational Diseases and Toxigenomics, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | - Noha M Shafik
- Department of Biochemistry, Tanta Faculty of Medicine, Tanta UniversityEgypt
| | - Reham A Mariah
- Department of Biochemistry, Tanta Faculty of Medicine, Tanta UniversityEgypt
| | - Noha El-Dabie
- Department of Pathology, Faculty of Medicine, Sohag UniversityEgypt
| | - Mohamed Abdel-Haleem
- Department of Ear, Nose and Throat, College of Medicine, Taibah UniversitySaudi Arabia
| | | | - Manal Mohamed Helmy Nabo
- Division of Pediatric Cardiology, Department of Pediatrics, Maternity and Children HospitalHail, Saudi Arabia
| | - Hassan El-Alaf
- Department of Medical Physiology, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | - Hussam Baghdadi
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Reda S Yousef
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | - Ahmed Alamir Mahmoud
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | - Salah Mohamed El Sayed
- Prophetic Medicine Course and Research, Taibah College of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | - Soliman M Amer
- Family and Community Medicine Department, Taibah UniversityAl-Medinah, Saudi Arabia
- Public Health and Community Medicine Department, Faculty of Medicine, Al-Azhar UniversityNew Damietta, Egypt
| |
Collapse
|
12
|
El Sayed SM, Aboonq MS, Aljehani YT, Hassan MA, Abou El-Magd RM, Abdelrahman AI, El-Tahlawi R, Nabo MMH, Yousef RS, Mahmoud AA, Elsayed YY, Abu-elnaga M, Soliman TM, Abdel-Gawad AR, Elshazley M, Baghdadi H, El-Sawy S, Mahmoud HS, El-Anzi ME, Alharbi MB. TaibUVID nutritional supplements help rapid cure of COVID-19 infection and rapid reversion to negative nasopharyngeal swab PCR: for better public prophylaxis and treatment of COVID-19 pandemic. Am J Blood Res 2020; 10:397-406. [PMID: 33489449 PMCID: PMC7811903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 05/16/2020] [Accepted: 11/04/2020] [Indexed: 06/12/2023]
Abstract
Public prophylaxis to decrease the emergence of new daily COVID-19 cases is vital. Adjuvant TaibUVID nutritional supplements are promising home-made or hospital-made supplements suggested for rapidly preventing and treating COVID-19 pandemic. We report here a 44 years old male physician who caught COVID-19 infection at hospital in Egypt with confirmed positive nasopharyngeal swab PCR. Ethical committee approval and informed patient's consent were gained before performing this study. Chest X-ray revealed increased bronchovascular markings. Close follow-up was done with no treatment given and he was sent for home isolation. Few days later, he developed progressive non-productive cough and a sense of difficult breathing with no associated fever or chest pain. An antitussive drug was given to him. The patient read about TaibUVID supplements from social media and started to feel improvement after TaibUVID inhalation therapy (using the heated solution of nigella sativa and chamomile five times a day). He also received a home-made TaibUVID nutritional supplement (nigella sativa, chamomile and natural honey) five times daily for four consecutive days. The next day, he was quite better with mild symptoms. Two days later, nasopharyngeal swab PCR was negative while other patients still had positive nasopharyngeal swabs. As few attacks of mild cough and breathing difficulty existed, he was admitted to hospital. A nasopharyngeal swab PCR was done for him again and the result was negative also. Blood gases were normal. He had lymphocytosis (possibly due to TaibUVID effects) that counteract lymphopenia seen in COVID-19 patients. Biochemical and hematological evaluation were quite normal apart from increased serum chloride and lactate dehydrogenase. There was a mild decrease in serum CO2 and alkaline phosphatase. Chest CT report revealed symmetrically inflated both lungs with non-specific focal nodular infiltrates (scattered in basal and medial lung segments) in left lower lobes with faint ground glass opacities. He was discharged home. Few days later, he was quite improved with no symptoms and returned to his work comfortably. In conclusion, TaibUVID nutritional supplements may be effective in rapidly changing the nasopharyngeal swab PCR from positive to negative. TaibUVID nutritional supplements are advisable as a natural, safe and effective prophylaxis to stop COVID-19 infectiousness, transmission and emergence of new cases. Clinical studies to investigate TaibUVID nutritional benefits are strongly recommended. TaibUVID may be promising and recommended for public prophylaxis to decrease emergence of new COVID-19 cases.
Collapse
Affiliation(s)
- Salah Mohamed El Sayed
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversityEgypt
- Prophetic Medicine Course and Research, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Moutasem Salih Aboonq
- Department of Medical Physiology, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Yasmeen Talal Aljehani
- Director of The Research and Studies Department of Health Affairs in Al-Madinah Region, Consultant Family Medicine and Trainer in Family Medicine Program for Postgraduate StudiesAl-Madinah Al-Munawwarah, Saudi Arabia
| | | | - Rabab M Abou El-Magd
- Department of Psychiatry, Faculty of Medicine and Dentistry, University of AlbertaCanada
- Institute of Genetic Engineering, City for Scientific Research and Technological ApplicationsAlexandria, Egypt
| | | | - Rehab El-Tahlawi
- Department of Microbiology, College of Medicine, Taibah UniversitySaudi Arabia
- Department of Microbiology, Faculty of Medicine, Zagazig UniversityEgypt
| | - Manal Mohamed Helmy Nabo
- Division of Pediatric Cardiology, Pediatrics Department, Maternity and Children HospitalHail, Saudi Arabia
| | - Reda S Yousef
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | - Ahmed Alamir Mahmoud
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | | | - Mostafa Abu-elnaga
- Department of Anatomy, College of Medicine, Al-Rayyan Medical CollegesAl-Madinah, Saudi Arabia
- Department of Anatomy, College of Medicine, Al-Azhar UniversityEgypt
| | - Tamer M Soliman
- Department of Clinical Pathology, Faculty of Medicine, Sohag UniversitySohag, Egypt
| | | | - Momen Elshazley
- Department of Medicine, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
- Department of Occupational Diseases and Toxigenomics, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | - Hussam Baghdadi
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Samer El-Sawy
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | - Hany Salah Mahmoud
- Center of Scientific Foundation for Experimental Studies and ResearchIsmailia, Egypt
| | - Mariam E El-Anzi
- Diabetic Center in King Fahd Hospital & Sayed Al-Shohada Primary Health Care CenterAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Mansour Barakah Alharbi
- Head of Training and Academic Affairs and Designated Institutional Official (DIO), King Fahad Hospital, Al-Madinah and Leader of Training and Academic Affairs TaskforceAl-Madinah Al-Munawwarah, Saudi Arabia
| |
Collapse
|
13
|
El-Shanshory M, Hablas NM, Shebel Y, Alhadramy O, El-Tahlawi R, Aboonq MS, Soliman TM, Abdel-Gawad AR, El Sayed SM, Abdallah HI, Mahmoud HS, El-Allaf H, El-Sawy S, Yousef RS, Abu-el Naga M, Mariah RA, Nabo MMH, Abdel-Haleem M, Mahmoud AA, Hassan MA, Al Arabi AH, Alnakhli AA, El Sayed SM. Al-hijamah (the triple S treatment of prophetic medicine) exerts cardioprotective, tissue-protective and immune potentiating effects in thalassemic children: a pilot clinical trial. Am J Blood Res 2020; 10:447-458. [PMID: 33489454 PMCID: PMC7811902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 05/12/2020] [Accepted: 10/24/2020] [Indexed: 06/12/2023]
Abstract
Thalassemia is a major health problem in affected children due to iron overload, increased oxidative stress, atherogenic lipid profile and tissue-damage. This study aims at investigating the cardioprotective and tissue-protective benefits of Al-hijamah and their impact on cell-mediated immunity for treating thalassemic children. This study aimed also at investigating the tissue-clearance principle of Taibah mechanism: whenever pathological substances are to be cleared from the human body, Al-hijamah is indicated. Al-hijamah was done to thalassemic children (15 males and 5 females having a mean age of 9.07 ± 4.26 years) using sterile disposable sets in a complete aseptic hospital environment. Prior ethical committee agreement (in addition to written patient's consents) was obtained from Tanta Faculty of Medicine, Egypt. Twenty thalassemic children received iron chelation therapy plus Al-hijamah for one session (30-60 minutes) versus an age and sex-matched thalassemic control group treated with iron chelation therapy only. Al-hijamah is a quite safe outpatient hematological procedure that significantly decreased serum cholesterol (from 129.75 ± 3.67 to 103.5 ± 4.18 mg/dl) and decreased serum triglycerides (from 109.25 ± 8.96 to 91.95 ± 7.22 mg/dl). Interestingly, Al-hijamah exerted significant tissue-protective effects (it decreased serum GPT from 98.65 ± 12.27 to 71.65 ± 32.78 U/L and serum GOT from 96.35 ± 14.33 to 69.35 ± 34.37 U/L). Al-hijamah-induced ferritin excretion caused decreased serum ferritin (high serum ferritin negatively correlated with cell mediated immunity). Al-hijamah exerted cardioprotective and tissue-protective and hypolipidemic effects. Al-hijamah decreased serum cholesterol and is cardioprotective for thalassemic patients as it protects against atherogenesis and atherosclerosis. Medical practice of Al-hijamah is strongly recommended in hospitals. Al-hijamah cleared blood significantly from causative pathological substances e.g. serum ferritin resulting in enhanced cell-mediated immunity (in agreement with the evidence-based Taibah mechanism).
Collapse
Affiliation(s)
- Mohamed El-Shanshory
- Prophetic Medicine Course and Research Group, Taibah College of MedicineAl-Madinah Al-Munawwarah, Saudi Arabia
- Department of Pediatrics, Tanta University Faculty of MedicineTanta, Gharbia, Egypt
| | | | - Yasmin Shebel
- Department of Pediatrics, Tanta University Faculty of MedicineTanta, Gharbia, Egypt
| | - Osama Alhadramy
- Division of Cardiology, Department of Medicine, Taibah College of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Rehab El-Tahlawi
- Department of Microbiology, College of Medicine, Taibah UniversitySaudi Arabia
- Department of Microbiology, Faculty of Medicine, Zagazig UniversityEgypt
| | - Moutasem Salih Aboonq
- Department of Medical Physiology, Taibah College of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Tamer M Soliman
- Department of Clinical Pathology, Sohag Faculty of Medicine, Sohag UniversitySohag, Egypt
| | | | - Sayed Mostafa El Sayed
- Department of Anatomy, Faculty of Medicine, Ain Shams UniversityEgypt
- Department of Anatomy, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Hesham I Abdallah
- Department of Anatomy, Faculty of Medicine, Ain Shams UniversityEgypt
- Department of Anatomy, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Hany Salah Mahmoud
- Center of Scientific Foundation for Experimental Studies and ResearchIsmailia, Egypt
| | - Hassan El-Allaf
- Department of Medical Physiology, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | - Samer El-Sawy
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | - Reda S Yousef
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | - Mostafa Abu-el Naga
- Department of Anatomy, College of Medicine, Al-Rayyan National CollegesAl-Madinah, Saudi Arabia
- Department of Anatomy, Faculty of Medicine, New Damietta, Al-Azhar UniversityEgypt
| | - Reham A Mariah
- Department of Medical Biochemistry, Tanta Faculty of Medicine, Tanta UniversityTanta, Egypt
| | - Manal Mohamed Helmy Nabo
- Division of Pediatric Cardiology, Pediatrics Department, Maternity and Children HospitalHail, Saudi Arabia
- Division of Pediatric Cardiology, Pediatrics Department, Sohag Teaching Hospital, Ministry of HealthSohag, Egypt
| | - Mohamed Abdel-Haleem
- Department of Ear, Nose and Throat, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Ahmed Alamir Mahmoud
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | | | - Areej Hesham Al Arabi
- Department of Cardiology, Governorate of Health, Uhud HospitalAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Abdullah Ahmed Alnakhli
- Department of Cardiology, Governorate of Health, Uhud HospitalAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Salah Mohamed El Sayed
- Prophetic Medicine Course and Research Group, Taibah College of MedicineAl-Madinah Al-Munawwarah, Saudi Arabia
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversityEgypt
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| |
Collapse
|
14
|
El Sayed SM, Aboonq MS, El Rashedy AG, Aljehani YT, Abou El-Magd RM, Okashah AM, El-Anzi ME, Alharbi MB, El-Tahlawi R, Nabo MMH, Yousef RS, Elshazley M, Abu-Elnaga M, Mahmoud HS, El-Alaf H, Abdelrahman AI, Abdel-Gawad AR, Soliman TM. Promising preventive and therapeutic effects of TaibUVID nutritional supplements for COVID-19 pandemic: towards better public prophylaxis and treatment (A retrospective study). Am J Blood Res 2020; 10:266-282. [PMID: 33224571 PMCID: PMC7675122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 06/01/2020] [Accepted: 08/23/2020] [Indexed: 06/11/2023]
Abstract
Adjuvant nutritional treatment is a commonly overlooked topic when treating lethal viral diseases as COVID-19 pandemic. We recently introduced TaibUVID nutritional supplements (nigella sativa, chamomile and natural honey) as adjuvants for COVID-19 contacts, patients and public prophylaxis. TaibUVID Forte adds costus, senna and fennel to TaibUVID. Meta-analyses and systematic reviews confirmed evidence-based therapeutic benefits of TaibUVID components in treating many human diseases e.g. diabetes mellitus and hypertension, common co-morbidities in COVID-19 patients. Double-blind clinical trials for treating COVID-19 patients with TaibUVID supplements were inapplicable. In this retrospective study in Egypt, COVID-19 patients and contacts knew TaibUVID via social media and voluntarily used them. 65% of COVID-19 patients (n = 13) received both pharmacological treatments and adjuvant TaibUVID nutritional supplements. 35% (n = 7) received TaibUVID only. Lymphopenia rapidly improved to lymphocytosis upon regular TaibUVID intake. TaibUVID nutritional supplements helped COVID-19 contacts' prophylaxis. 70% of COVID-19 contacts (n = 14) (on regular TaibUVID intake) did not get SARS-COV2 infection. 30% (n = 6) were not using TaibUVID regularly and got mild flu-like symptoms and upon using both TaibUVID and pharmacological treatments, all improved and got negative nasopharyngeal swabs PCR. COVID-19 contacts were mainly physicians (40%, n = 8) (dealing with COVID-19 patients daily) and members of physicians' families (45%). Main presentations reported by COVID-19 patients (n = 20) were cough (90%), fever (55%), anosmia (45%), taste loss (45%), sore throat (45%), respiratory difficulty (45%) and malaise (35%). TaibUVID inhalation therapy (nigella sativa/anthemis/costus solution nebulization) was used by 65% of COVID-19 patients (n = 13) and alleviated respiratory manifestations e.g. cough and respiratory difficulty and was life-saving in some cases. 70% of COVID-19 patients (n = 14) improved in 1-4 days, 25% (n = 5) improved in 5-10 days while 5% improved in more than 10 days. TaibUVID nutritional supplements were tolerable and significantly satisfactory (P<0.01). 81.25% of COVID-19 patients (n = 13) did not report side effects. 18.25% (n = 3) reported mild diarrhea, sweating and hyperglycemia (not confirmed to be due to TaibUVID supplements). 31.25% of patients (n = 5) were satisfied by 100% with TaibUVID nutritional supplements. 37.5% (n = 6) of patients were satisfied by 75%. In conclusion, TaibUVID nutritional supplements are recommended for public prophylaxis (to decrease emergence of new cases) and treatment in COVID-19 pandemic. Clinical trials and further investigations are recommended.
Collapse
Affiliation(s)
- Salah Mohamed El Sayed
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversityEgypt
- Prophetic Medicine and Integrative Medicine Course and Research, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Moutasem Salih Aboonq
- Department of Medical Physiology, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Amr Gamal El Rashedy
- Department of Gastroenterology and Infectious Diseases, Sohag Fever HospitalSohag, Egypt
| | - Yasmeen Talal Aljehani
- Director of The Research and Studies Department of Health Affairs in Al-Madinah Region, Consultant Family Medicine and Trainer in Family Medicine Program for Postgraduate StudiesAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Rabab M Abou El-Magd
- Department of Psychiatry, Faculty of Medicine and Dentistry, University of AlbertaEdmonton, Alberta, Canada
- Genetic Engineering and Biotechnology Research Institute, City for Scientific Research and Technology ApplicationsAlexandria, Egypt
| | - Ahmed M Okashah
- Academic Affairs Director and Consultant Clinical Immunologist, Al-Madinah Directorate of Health, Al-Madinah Al-Munawwarah, Ministry of HealthSaudi Arabia
| | - Mariam E El-Anzi
- Diabetic Center in King Fahd Hospital & Sayed Al-Shohada Primary Health Care CenterAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Mansour Barakah Alharbi
- Head of Training and Academic Affairs and Designated Institutional Official (DIO), King Fahad Hospital, Al-Madinah and Leader of Training and Academic Affairs TaskforceAl-Madinah Al-Munawwarah, Saudi Arabia
| | - Rehab El-Tahlawi
- Department of Microbiology, College of Medicine, Taibah UniversitySaudi Arabia
- Department of Microbiology, Faculty of Medicine, Zagazig UniversityEgypt
| | - Manal Mohamed Helmy Nabo
- Division of Pediatric Cardiology, Pediatrics Department, Maternity and Children HospitalHail, Saudi Arabia
- Division of Pediatric Cardiology, Pediatrics Department, Sohag Teaching HospitalSohag, Egypt
| | - Reda S Yousef
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | - Momen Elshazley
- Department of Medicine, Taibah Faculty of Medicine, Taibah UniversityAl-Madinah Al-Munawwarah, Saudi Arabia
- Department of Occupational Diseases and Toxigenomics, Sohag Faculty of Medicine, Sohag UniversityEgypt
| | - Mostafa Abu-Elnaga
- Department of Anatomy, College of Medicine, King Abdul-Aziz UniversityJeddah, Saudi Arabia
- Department of Anatomy, Faculty of Medicine, Al-Azhar UniversityEgypt
| | - Hany Salah Mahmoud
- Center of Scientific Foundation for Experimental Studies and ResearchIsmailia, Egypt
| | - Hassan El-Alaf
- Department of Physiology, Faculty of Medicine, Sohag UniversityEgypt
| | | | | | - Tamer M Soliman
- Department of Clinical Pathology, Sohag Faculty of Medicine, Sohag UniversityEgypt
| |
Collapse
|
15
|
Hamouda O, Sweilam M, Abdellah A, El Sayed SM. Evaluation of pioneering introduction of integrative and prophetic medicine education in an Arabic medical school (Taibah University, Saudi Arabia): 10 years' experience. J Int Med Res 2019; 47:2157-2165. [PMID: 30966841 PMCID: PMC6567772 DOI: 10.1177/0300060519831174] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Objective To assess physicians' attitudes toward integrative medicine (IM), including prophetic medicine (PM), combining the best of modern medicine with the best of alternative and complementary medicine. Most physicians are unfamiliar with IM and PM and may thus be against them and it may communicate that to the public. Methods Taibah University (Saudi Arabia) is the sole university in the Arab world with an educational medical course in IM and PM. We assessed IM scientific knowledge and students’ feedback regarding course contents, course design, and teaching methods. A questionnaire was administered to medical students who attended the course. Results A total 650 students (264 men, 386 women) participated in the study; 83% considered the IM (including PM) education beneficial. Among them, 49.6% (range, 60% to 100%) reported that they gained medical benefit from studying IM, and 74% expressed strong positive attitudes toward studying IM. Among participants, 65.8% agreed with the current course topics, without the need to add or delete any topics; 95% of students were satisfied with IM and PM education. Students' interest in the branches of IM included all IM subspecialties. Conclusion IM and PM education should be globally generalized to all medical students, physicians, and health practitioners, particularly in Arabic universities.
Collapse
Affiliation(s)
- Osama Hamouda
- 1 Assistant professor, Integrative Medicine and Prophetic Medicine Course and Research, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia.,2 Department of Dermatology, Maternity and Children Hospital, Ministry of Health, Al-Madinah Al-Munawwarah, Saudi Arabia
| | - Mohammad Sweilam
- 3 Professor, Department of Statistics, Community College, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia.,4 Professor, Department of Statistics, Faculty of Commerce, Benha University, Egypt
| | - Antar Abdellah
- 5 Professor of TESOL, Department of Curricula and instruction, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia.,6 Professor of TESOL, Department of Curricula and instruction, College of Education, South Valley University, Qena, Egypt
| | - Salah Mohamed El Sayed
- 1 Assistant professor, Integrative Medicine and Prophetic Medicine Course and Research, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia.,7 Assistant professor, Department of Medical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia.,8 Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt
| |
Collapse
|
16
|
El-Shanshory M, Hablas NM, Shebl Y, Fakhreldin AR, Attia M, Almaramhy HH, Baghdadi H, Ayat M, Albeihany A, El-Dardear A, Ibrahim HA, Mahmoud HS, Nabo MMH, El Sayed SM. Al-hijamah (wet cupping therapy of prophetic medicine) significantly and safely reduces iron overload and oxidative stress in thalassemic children: a novel pilot study. J Blood Med 2018; 9:241-251. [PMID: 30588142 PMCID: PMC6300367 DOI: 10.2147/jbm.s170523] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
Background Thalassemia is a major health problem due to iron overload, iron deposition and oxidative stress-induced tissue damage. Here, we introduce Al-hijamah (a minor surgical excretory procedure) as a novel percutaneous iron excretion therapy. Al-hijamah is a wet cupping therapy of prophetic medicine, and prophet Muhammad, peace be upon him, strongly recommended Al-hijamah, saying: “The best of your treatment is Al-hijamah”. Aim of the study Our study aimed at investigating the safety, iron chelation, pharmacological potentiation and oxidant clearance effects exerted by Al-hijamah to thalassemic children. Patients and methods Ethical committee’s approval and patients’ written agreement consents were obtained. We treated 20 thalassemic children (15 males and five females aged 9.07±4.26 years) with iron chelation therapy (ICT) plus Al-hijamah (using sterile disposable sets and in a complete aseptic environment) vs a control group treated with ICT only. This clinical trial was registered in the ClinicalTrial.gov registry under the name “Study of the Therapeutic Benefits of Al-hijamah in Children with Beta Thalassemia Major” (identifier no NCT 02761395) on 30 January 2016. Results Al-hijamah was quite simple, safe, effective, tolerable (with no side effects) and time-saving procedure (30–60 minutes). A single session of Al-hijamah significantly reduced iron overload (P<0.001) in all thalassemic children. Al-hijamah significantly decreased serum ferritin by 25.22% (from 3,778.350±551.633 ng/mL to 2,825.300±558.94 ng/mL), significantly decreased oxidative stress by 68.69% (P<0.05; serum malondialdehyde dropped from 42.155±12.42 to 13.195±0.68 nmol/L), exerted pharmacological potentiation to ICT and significantly increased total antioxidant capacity (P<0.001) by 260.95% (from 13.195±0.68 nmol/L to 42.86±12.40 nmol/L through excreting reactive oxygen species). Moreover, therapeutic indices for evaluating Al-hijamah were promising. Conclusion Al-hijamah is a novel, safe, effective percutaneous iron excretion therapy through percutaneous iron excretion with minimal blood loss in agreement with the evidence-based Taibah mechanism. Al-hijamah is an effective outpatient hematological procedure that is safer than many pediatric procedures such as catheterization, hemofiltration and dialysis. Increasing the number of cups during Al-hijamah session or the number of sessions reduces iron overload more strongly. Medical practice of Al-hijamah is strongly recommended in hospitals.
Collapse
Affiliation(s)
- Mohamed El-Shanshory
- Prophetic Medicine Course and Research, Taibah College of Medicine, Medina, Saudi Arabia, .,Department of Pediatrics, Tanta University Faculty of Medicine, Tanta Gharbia, Egypt
| | - Nahed M Hablas
- Department of Pediatrics, Tanta University Faculty of Medicine, Tanta Gharbia, Egypt
| | - Yasmin Shebl
- Department of Pediatrics, Tanta University Faculty of Medicine, Tanta Gharbia, Egypt
| | - Ahmed R Fakhreldin
- Department of Pediatrics, Aswan Faculty of Medicine, Aswan University, Aswan, Egypt
| | - Mohamed Attia
- Department of Clinical Pathology, Tanta Faculty of Medicine, Tanta University, Tanta, Egypt
| | - Hamdi H Almaramhy
- Department of Surgery, Taibah Faculty of Medicine, Taibah University, Medina, Saudi Arabia
| | - Hussam Baghdadi
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Medina, Saudi Arabia,
| | - Mongi Ayat
- Prophetic Medicine Course and Research, Taibah College of Medicine, Medina, Saudi Arabia, .,Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Medina, Saudi Arabia,
| | - Amal Albeihany
- Department of Hematology, King Fahd Hospital, Ministry of Health, Medina, Saudi Arabia
| | - Amr El-Dardear
- Prophetic Medicine Course and Research, Taibah College of Medicine, Medina, Saudi Arabia, .,Department of Pediatrics, Faculty of Medicine, Taibah University, Medina, Saudi Arabia.,Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt
| | - Hoda Ali Ibrahim
- Department of Biochemistry, Tanta Faculty of Medicine, Tanta University, Tanta, Egypt
| | | | - Manal Mohamed Helmy Nabo
- Division of Pediatric Intensive Care Unit, King Fahad Hospital, Ministry of Health, Medina, Saudi Arabia.,Division of Pediatric Cardiology, Pediatrics Department, Sohag Teaching Hospital, Ministry of Health, Sohag, Egypt
| | - Salah Mohamed El Sayed
- Prophetic Medicine Course and Research, Taibah College of Medicine, Medina, Saudi Arabia, .,Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Medina, Saudi Arabia, .,Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt,
| |
Collapse
|
17
|
El Sayed SM. Enhancing anticancer effects, decreasing risks and solving practical problems facing 3-bromopyruvate in clinical oncology: 10 years of research experience. Int J Nanomedicine 2018; 13:4699-4709. [PMID: 30154655 PMCID: PMC6103555 DOI: 10.2147/ijn.s170564] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
3-Bromopyruvate (3BP) is a promising powerful general anticancer agent. Unfortunately, 3BP release faces many practical and biochemical problems in clinical human oncology, for example, 3BP induces burning venous sensation (during intravenous infusion) and rapid inactivation by thiol groups of glutathione and proteins. 3BP exhibits resistance in glutathione-rich tumors without being able to exert selective targeting. 3BP does not cross the blood–brain barrier and cannot treat nervous system tumors. Importantly, 3BP cannot persist in tumor tissues due to the phenomenon of enhanced permeability and retention effect. Here, the author presents the practical solutions for clinical problems facing 3BP use in clinical oncology, based on over 10 years of experience in 3BP research. Crude (unformulated 3BP that is purchased from chemical companies without being formulated in liposomes or other nanocarriers) should not be administered in clinical oncology. Instead, 3BP is better formulated with liposomes, polyethylene glycol (PEG), PEGylated liposomes (stealth liposomes) or perillyl alcohol that are used currently with many chemotherapeutics for treating clinical tumors in cancer patients. Formulating 3BP with targeted liposomes, for example, with folate, transferrin or other ligands, improves tumor targeting. Formulating 3BP with liposomes, PEG, stealth liposomes or perillyl alcohol may improve its pharmacokinetics, hide it from thiols in the circulation, protect it from serum proteins and enzymes, prevent burning sensation, prolong 3BP’s longevity and facilitate crossing the BBB. Formulating 3BP with stealth liposomes protects 3BP from the reticuloendothelial cells. Liposomal 3BP formulations may retain 3BP better inside the relatively large tumor capillary pores (abolish enhanced permeability and retention effect) sparing normal tissues, facilitate new delivery routes for 3BP (eg, topical and intranasal 3BP administration using perillyl alcohol) and improve cancer cytotoxicity. Formulating 3BP may be promising in overcoming many obstacles in clinical oncology.
Collapse
Affiliation(s)
- Salah Mohamed El Sayed
- Department of Clinical Biochemistry and Molecular Medicine, Taibah College of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia, .,Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt,
| |
Collapse
|
18
|
El Sayed SM, Baghdadi H, Zolaly M, Almaramhy HH, Ayat M, Donki JG. The promising anticancer drug 3-bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence-based view. Med Hypotheses 2017; 100:67-77. [DOI: 10.1016/j.mehy.2017.01.014] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2016] [Revised: 10/11/2016] [Accepted: 01/21/2017] [Indexed: 01/22/2023]
|
19
|
El Sayed SM, Abdelrahman AA, Ozbak HA, Hemeg HA, Kheyami AM, Rezk N, El-Ghoul MB, Nabo MMH, Fathy YM. Updates in diagnosis and management of Ebola hemorrhagic fever. J Res Med Sci 2016; 21:84. [PMID: 28163730 PMCID: PMC5244689 DOI: 10.4103/1735-1995.192500] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/06/2016] [Revised: 02/22/2016] [Accepted: 05/01/2016] [Indexed: 12/13/2022]
Abstract
Ebola hemorrhagic fever is a lethal viral disease transmitted by contact with infected people and animals. Ebola infection represents a worldwide health threat causing enormous mortality rates and fatal epidemics. Major concern is pilgrimage seasons with possible transmission to Middle East populations. In this review, we aim to shed light on Ebola hemorrhagic fever as regard: virology, transmission, biology, pathogenesis, clinical picture, and complications to get the best results for prevention and management. We also aim to guide future research to new therapeutic perspectives to precise targets. Our methodology was to review the literature extensively to make an overall view of the biology of Ebola virus infection, its serious health effects and possible therapeutic benefits using currently available remedies and future perspectives. Key findings in Ebola patients are fever, hepatic impairment, hepatocellular necrosis, lymphopenia (for T-lymphocyte and natural killer cells) with lymphocyte apoptosis, hemorrhagic manifestations, and complications. Pathogenesis in Ebola infection includes oxidative stress, immune suppression of both cell-mediated and humoral immunities, hepatic and adrenal impairment and failure, hemorrhagic fever, activation of deleterious inflammatory pathways, for example, tumor necrosis factor-related apoptosis-inducing ligand, and factor of apoptotic signal death receptor pathways causing lymphocyte depletion. Several inflammatory mediators and cytokines are involved in pathogenesis, for example, interleukin-2, 6, 8, and 10 and others. In conclusion, Ebola hemorrhagic fever is a serious fatal viral infection that can be prevented using strict health measures and can be treated to some extent using some currently available remedies. Newer treatment lines, for example, prophetic medicine remedies as nigella sativa may be promising.
Collapse
Affiliation(s)
- Salah Mohamed El Sayed
- Department of Clinical Biochemistry and Molecular Medicine, Taibah College of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia; Department of Clinical Biochemistry, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt
| | - Ali A Abdelrahman
- Department of Medical Laboratories Technology, Faculty of Applied Medical Sciences, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia
| | - Hani Adnan Ozbak
- Department of Medical Laboratories Technology, Faculty of Applied Medical Sciences, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia
| | - Hassan Abdullah Hemeg
- Department of Medical Laboratories Technology, Faculty of Applied Medical Sciences, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia
| | - Ali Mohammed Kheyami
- Molecular Virology Unit, Central Laboratories and Blood Bank, Directorate of Health, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia
| | - Nasser Rezk
- Department of Medical Laboratories Technology, Faculty of Applied Medical Sciences, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia
| | - Mohamed Baioumy El-Ghoul
- Department of Medicine, Uhud General Hospital, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia
| | - Manal Mohamed Helmy Nabo
- Department of Pediatrics, Sohag Teaching Hospital, Sohag, Egypt; Department of Pediatrics, Division of Pediatric Cardiology, Maternity and Children Hospital, King Abdullah Medical City, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia
| | | |
Collapse
|
20
|
El Sayed SM, Abou-Taleb A, Mahmoud HS, Baghdadi H, Maria RA, Ahmed NS, Nabo MMH. Corrigendum to “Percutaneous excretion of iron and ferritin (through Al-hijamah) as a novel treatment for iron overload in beta-thalassemia major, hemochromatosis and sideroblastic anemia” [Med. Hypotheses 83 (2014) 238–246]. Med Hypotheses 2015. [DOI: 10.1016/j.mehy.2015.06.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
21
|
Baghdadi H, Abdel-Aziz N, Ahmed NS, Mahmoud HS, Barghash A, Nasrat A, Nabo MMH, El Sayed SM. Ameliorating Role Exerted by Al-Hijamah in Autoimmune Diseases: Effect on Serum Autoantibodies and Inflammatory Mediators. Int J Health Sci (Qassim) 2015; 9:207-232. [PMID: 26309442 PMCID: PMC4538900] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023] Open
Abstract
Autoimmune diseases have common properties characterized by abnormal blood chemistry with high serum autoimmune antibodies, and inflammatory mediators. Those causative pathological substances (CPS) cannot be excreted by physiological mechanisms. Current treatments for autoimmune diseases involve steroids, cytotoxic drugs, plasmapheresis and monoclonal antibodies. Wet cupping therapy (WCT) of prophetic medicine is called Al-hijamah that treats numerous diseases having different etiology and pathogenesis via a pressure-dependent and size-dependent non-specific filtration then excretion of CPS causing clearance of blood and interstitial fluids. Al-hijamah clears blood passing through the fenestrated skin capillaries. Medical bases of Al-hijamah were reported in the evidence-based Taibah mechanism (Taibah theory). Al-hijamah was reported to be an excellent treatment for rheumatoid arthritis that improved patients' blood chemistry and induced significant clinical improvement and pharmacological potentiation. Al-hijamah improved the natural immunity and suppressed the pathological immunity through decreasing the serum level of autoantibodies, inflammatory mediators, and serum ferritin (a key player in autoimmunity). Al-hijamah reduced significantly pain severity, number of swollen joints and disease activity with no significant side effects. Main steps of Al-hijamah are skin suction (cupping), scarification (sharatmihjam in Arabic) and second suction (triple S technique) that is better therapeutically than the traditional WCT (double S technique). Whenever an excess noxious substance is to be removed from patients' blood and interstitial fluids, Al-hijamah is indicated. Shartatmihjam is a curative treatment in prophetic teachings according to the prophetic hadeeth: "Cure is in three: in shartatmihjam, oral honey and cauterization. I do not recommend my nation to cauterize". Al-hijamah may have better therapeutic benefits than plasmapheresis. Al-hijamah may be promising in treating autoimmune diseases as a sole treatment or adjuvant treatment.
Collapse
Affiliation(s)
- Hussam Baghdadi
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia
| | - Nada Abdel-Aziz
- Department of Medical Microbiology and Immunology, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia
- Department of Medical Microbiology and Immunology, Sohag Faculty of Medicine, Sohag University, Egypt
| | - Nagwa Sayed Ahmed
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University, Egypt
| | - Hany Salah Mahmoud
- World Federation of Alternative and Complementary Medicine, Cairo Regional Headquarter, Cairo, Egypt
| | - Ayman Barghash
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia
- Department of Medical Biochemistry, Alexandria Faculty of Medicine, Alexandria University, Egypt
| | - Abdullah Nasrat
- Balaghsoun Clinics compound, Jeddah, Kingdom of Saudi Arabia
| | - Manal Mohamed Helmy Nabo
- Department of Pediatrics, Sohag Teaching Hospital, Sohag, Egypt
- Division of Pediatric cardiology, Department of Pediatrics, Maternity and Children Hospital, King Abdullah Medical City, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia
| | - Salah Mohamed El Sayed
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University, Egypt
| |
Collapse
|
22
|
El Sayed SM, Baghdadi H, Abou-Taleb A, Mahmoud HS, Maria RA, Ahmed NS, Helmy Nabo MM. Al-hijamah and oral honey for treating thalassemia, conditions of iron overload, and hyperferremia: toward improving the therapeutic outcomes. J Blood Med 2014; 5:219-37. [PMID: 25382989 PMCID: PMC4222535 DOI: 10.2147/jbm.s65042] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Iron overload causes iron deposition and accumulation in the liver, heart, skin, and other tissues resulting in serious tissue damages. Significant blood clearance from iron and ferritin using wet cupping therapy (WCT) has been reported. WCT is an excretory form of treatment that needs more research efforts. WCT is an available, safe, simple, economic, and time-saving outpatient modality of treatment that has no serious side effects. There are no serious limitations or precautions to discontinue WCT. Interestingly, WCT has solid scientific and medical bases (Taibah mechanism) that explain its effectiveness in treating many disease conditions differing in etiology and pathogenesis. WCT utilizes an excretory physiological principle (pressure-dependent excretion) that resembles excretion through renal glomerular filtration and abscess evacuation. WCT exhibits a percutaneous excretory function that clears blood (through fenestrated skin capillaries) and interstitial fluids from pathological substances without adding a metabolic or detoxification burden on the liver and the kidneys. Interestingly, WCT was reported to decrease serum ferritin (circulating iron stores) significantly by about 22.25% in healthy subjects (in one session) and to decrease serum iron significantly to the level of causing iron deficiency (in multiple sessions). WCT was reported to clear blood significantly of triglycerides, low-density lipoprotein (LDL) cholesterol, total cholesterol, uric acid, inflammatory mediators, and immunoglobulin antibodies (rheumatoid factor). Moreover, WCT was reported to enhance the natural immunity, potentiate pharmacological treatments, and to treat many different disease conditions. There are two distinct methods of WCT: traditional WCT and Al-hijamah (WCT of prophetic medicine). Both start and end with skin sterilization. In traditional WCT, there are two steps, skin scarification followed by suction using plastic cups (double S technique); Al-hijamah is a three-step procedure that includes skin suction using cups, scarification (shartat mihjam in Arabic), and second skin suction (triple S technique). Al-hijamah is a more comprehensive technique and does better than traditional WCT, as Al-hijamah includes two pressure-dependent filtration steps versus one step in traditional WCT. Whenever blood plasma is to be cleared of an excess pathological substance, Al-hijamah is indicated. We will discuss here some reported hematological and therapeutic benefits of Al-hijamah, its medical bases, methodologies, precautions, side effects, contraindications, quantitative evaluation, malpractice, combination with oral honey treatment, and to what extent it may be helpful when treating thalassemia and other conditions of iron overload and hyperferremia.
Collapse
Affiliation(s)
- Salah Mohamed El Sayed
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt ; Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia
| | - Hussam Baghdadi
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia
| | - Ashraf Abou-Taleb
- Department of Pediatrics, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt
| | - Hany Salah Mahmoud
- World Federation of Alternative and Complementary Medicine, Cairo Regional Headquarter, Cairo, Egypt
| | - Reham A Maria
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia ; Department of Medical Biochemistry, Tanta Faulty of Medicine, Tanta University, Tanta, Egypt
| | - Nagwa S Ahmed
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt
| | - Manal Mohamed Helmy Nabo
- Department of Pediatrics, Sohag Teaching Hospital, Sohag, Egypt ; Division of Pediatric Cardiology, Department of Pediatrics, Maternity and Children Hospital, King Abdullah Medical City, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia
| |
Collapse
|
23
|
El Sayed SM, Abou-Taleb A, Mahmoud HS, Baghdadi H, Maria RA, Ahmed NS, Nabo MMH. Percutaneous excretion of iron and ferritin (through Al-hijamah) as a novel treatment for iron overload in beta-thalassemia major, hemochromatosis and sideroblastic anemia. Med Hypotheses 2014; 83:238-46. [PMID: 24857772 DOI: 10.1016/j.mehy.2014.04.001] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2013] [Revised: 09/25/2013] [Accepted: 04/01/2014] [Indexed: 11/24/2022]
Abstract
Iron overload is a big challenge when treating thalassemia (TM), hemochromatosis and sideroblastic anemia. It persists even after cure of TM with bone marrow transplantation. Iron overload results from increased iron absorption and repeated blood transfusions causing increased iron in plasma and interstitial fluids. Iron deposition in tissues e.g. heart, liver, endocrine glands and others leads to tissue damage and organ dysfunction. Iron chelation therapy and phlebotomy for iron overload have treatment difficulties, side effects and contraindications. As mean iron level in skin of TM patients increases by more than 200%, percutaneous iron excretion may be beneficial. Wet cupping therapy (WCT) is a simple, safe and economic treatment. WCT is a familiar treatment modality in some European countries and in Chinese hospitals in treating different diseases. WCT was reported to clear both blood plasma and interstitial spaces from causative pathological substances (CPS). Standard WCT method is Al-hijamah (cupping, puncturing and cupping, CPC) method of WCT that was reported to clear blood and interstitial fluids better than the traditional WCT (puncturing and cupping method, PC method of WCT). In other word, traditional WCT may be described as scarification and suction method (double S technique), while Al-hijamah may be described as suction, scarification and suction method (triple S technique). Al-hijamah is a more comprehensive treatment modality that includes all steps and therapeutic benefits of traditional dry cupping therapy and WCT altogether according to the evidence-based Taibah mechanism (Taibah theory). During the first cupping step of Al-hijamah, a fluid mixture is collected inside skin uplifting due to the effect of negative pressure inside sucking cups. This fluid mixture contains collected interstitial fluids with CPS (iron, ferritin and hemolyzed RBCs in thalassemia), filtered fluids (from blood capillaries) with iron and hemolyzed blood cells (hemolyzed RBCs, WBCs and platelets). That fluid mixture does not contain intact blood cells (having diameters in microns) that are too big to pass through pores of skin capillaries (6-12nm in diameter) and cannot be filtered. Puncturing skin upliftings and applying second cupping step excrete collected fluids. Skin scarifications (shartat mihjam in Arabic) should be small, superficial (0.1mm in depth), short (1-2mm in length), multiple, evenly distributed and confined to skin upliftings. Sucking pressure inside cups (-150 to -420mmHg) applied to skin is transmitted to around skin capillaries to be added to capillary hydrostatic pressure (-33mmHg at arterial end of capillaries and -13mmHg at venous end of capillaries) against capillary osmotic pressure (+20mmHg). This creates a pressure gradient and a traction force across skin and capillaries and increases filtration at arterial end of capillaries at net pressure of -163 to -433mmHg and at venous end of capillaries at net pressure of -143 to -413mmHg resulting in clearance of blood from CPS (iron, ferritin and hemolyzed blood cells). Net filtration pressure at renal glomeruli is 10mmHg i.e. Al-hijamah exerts a more pressure-dependent filtration than renal glomeruli. Al-hijamah may benefit patients through inducing negative iron balance. Interestingly, Al-hijamah was reported to decrease serum ferritin significantly (by about 22%) in healthy subjects while excessive traditional WCT was reported to cause iron deficiency anemia. Al-hijamah is a highly recommended treatment in prophetic medicine. In conclusion, Al-hijamah may be a promising adjuvant treatment for iron overload in TM, hemochromatosis and sideroblastic anemia.
Collapse
Affiliation(s)
- Salah Mohamed El Sayed
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia. Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University, Egypt
| | - Ashraf Abou-Taleb
- Department of Pediatrics, Sohag Faculty of Medicine, Sohag University, Egypt
| | - Hany Salah Mahmoud
- World Federation of Alternative and Complementary Medicine, Cairo Regional Headquarter, Cairo, Egypt
| | - Hussam Baghdadi
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia
| | - Reham A Maria
- Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia; Department of Medical Biochemistry, Tanta Faulty of Medicine, Tanta University, Egypt
| | - Nagwa Sayed Ahmed
- Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University, Egypt
| | - Manal Mohamed Helmy Nabo
- Department of Pediatrics, Sohag Teaching Hospital, Sohag, Egypt; Division of Pediatric Cardiology, Department of Pediatrics, Maternity and Children Hospital, King Abdullah Medical City, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia
| |
Collapse
|
24
|
El Sayed SM, Mohamed WG, Seddik MAH, Ahmed ASA, Mahmoud AG, Amer WH, Helmy Nabo MM, Hamed AR, Ahmed NS, Abd-Allah AAR. Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study. Chin J Cancer 2014; 33:356-64. [PMID: 24636230 PMCID: PMC4110469 DOI: 10.5732/cjc.013.10111] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
3-Bromopyruvate (3BP) is a new, promising anticancer alkylating agent with several notable functions. In addition to inhibiting key glycolysis enzymes including hexokinase II and lactate dehydrogenase (LDH), 3BP also selectively inhibits mitochondrial oxidative phosphorylation, angiogenesis, and energy production in cancer cells. Moreover, 3BP induces hydrogen peroxide generation in cancer cells (oxidative stress effect) and competes with the LDH substrates pyruvate and lactate. There is only one published human clinical study showing that 3BP was effective in treating fibrolamellar hepatocellular carcinoma. LDH is a good measure for tumor evaluation and predicts the outcome of treatment better than the presence of a residual tumor mass. According to the Warburg effect, LDH is responsible for lactate synthesis, which facilitates cancer cell survival, progression, aggressiveness, metastasis, and angiogenesis. Lactate produced through LDH activity fuels aerobic cell populations inside tumors via metabolic symbiosis. In melanoma, the most deadly skin cancer, 3BP induced necrotic cell death in sensitive cells, whereas high glutathione (GSH) content made other melanoma cells resistant to 3BP. Concurrent use of a GSH depletor with 3BP killed resistant melanoma cells. Survival of melanoma patients was inversely associated with high serum LDH levels, which was reported to be highly predictive of melanoma treatment in randomized clinical trials. Here, we report a 28-year-old man presented with stage IV metastatic melanoma affecting the back, left pleura, and lung. The disease caused total destruction of the left lung and a high serum LDH level (4,283 U/L). After ethics committee approval and written patient consent, the patient received 3BP intravenous infusions (1-2.2 mg/kg), but the anticancer effect was minimal as indicated by a high serum LDH level. This may have been due to high tumor GSH content. On combining oral paracetamol, which depletes tumor GSH, with 3BP treatment, serum LDH level dropped maximally. Although a slow intravenous infusion of 3BP appeared to have minimal cytotoxicity, its anticancer efficacy via this delivery method was low. This was possibly due to high tumor GSH content, which was increased after concurrent use of the GSH depletor paracetamol. If the anticancer effectiveness of 3BP is less than expected, the combination with paracetamol may be needed to sensitize cancer cells to 3BP-induced effects.
Collapse
Affiliation(s)
- Salah Mohamed El Sayed
- Department of Medical Oncology and Nuclear Medicine, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt. ,
| | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
El Sayed SM, Mahmoud AA, El Sawy SA, Abdelaal EA, Fouad AM, Yousif RS, Hashim MS, Hemdan SB, Kadry ZM, Abdelmoaty MA, Gabr AG, Omran FM, Nabo MMH, Ahmed NS. Warburg effect increases steady-state ROS condition in cancer cells through decreasing their antioxidant capacities (anticancer effects of 3-bromopyruvate through antagonizing Warburg effect). Med Hypotheses 2013; 81:866-70. [PMID: 24071366 DOI: 10.1016/j.mehy.2013.08.024] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2013] [Revised: 08/20/2013] [Accepted: 08/23/2013] [Indexed: 12/12/2022]
Abstract
Cancer cells undergo an increased steady-state ROS condition compared to normal cells. Among the major metabolic differences between cancer cells and normal cells is the dependence of cancer cells on glycolysis as a major source of energy even in the presence of oxygen (Warburg effect). In Warburg effect, glucose is catabolized to lactate that is extruded through monocarboxylate transporters to the microenvironment of cancer cells, while in normal cells, glucose is metabolized into pyruvate that is not extruded. Pyruvate is a potent antioxidant, while lactate has no antioxidant effect. Pyruvate in normal cells may be further metabolized to acetyl CoA and then through Krebs cycle with production of antioxidant intermediates e.g. citrate, malate and oxaloacetate together with the reducing equivalents (NADH.H+). Through activity of mitochondrial transhydrogenase, NADH.H+ replenishes NADPH.H+, coenzyme of glutathione reductase which replenishes reduced form of glutathione (potent antioxidant). This enhances antioxidant capacities of normal cells, while cancer cells exhibiting Warburg effect may be deprived of all that antioxidant capabilities due to loss of extruded lactate (substrate for Krebs cycle). Although intrinsic oxidative stress in cancer cells is high, it may be prevented from reaching progressively increasing levels that are cytotoxic to cancer cells. This may be due to some antioxidant effects exerted by hexokinase II (HK II) and NADPH.H+ produced through HMP shunt. Glycolytic phenotype in cancer cells maintains a high non-toxic oxidative stress in cancer cells and may be responsible for their malignant behavior. Through HK II, glycolysis fuels the energetic arm of malignancy, the mitotic arm of malignancy (DNA synthesis through HMP shunt pathway) and the metastatic arm of malignancy (hyaluronan synthesis through uronic acid pathway) in addition to the role of phosphohexose isomerase (autocrine motility factor). All those critical three arms start with the substrate G6P that is a direct product of HK II. 3-bromopyruvate (3BP, inhibitor of HK II) may prove as a promising anticancer and antimetastatic agent based on antagonizing the Warburg effect and disturbing the malignant behavior in cancer cells.
Collapse
|
26
|
Nakano A, Tsuji D, Miki H, Cui Q, Sayed SME, Ikegame A, Oda A, Amou H, Nakamura S, Harada T, Fujii S, Kagawa K, Takeuchi K, Sakai A, Ozaki S, Okano K, Nakamura T, Itoh K, Matsumoto T, Abe M. Glycolysis inhibition inactivates ABC transporters to restore drug sensitivity in malignant cells. PLoS One 2011; 6:e27222. [PMID: 22073292 PMCID: PMC3206937 DOI: 10.1371/journal.pone.0027222] [Citation(s) in RCA: 75] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2011] [Accepted: 10/12/2011] [Indexed: 12/14/2022] Open
Abstract
Cancer cells eventually acquire drug resistance largely via the aberrant expression of ATP-binding cassette (ABC) transporters, ATP-dependent efflux pumps. Because cancer cells produce ATP mostly through glycolysis, in the present study we explored the effects of inhibiting glycolysis on the ABC transporter function and drug sensitivity of malignant cells. Inhibition of glycolysis by 3-bromopyruvate (3BrPA) suppressed ATP production in malignant cells, and restored the retention of daunorubicin or mitoxantrone in ABC transporter-expressing, RPMI8226 (ABCG2), KG-1 (ABCB1) and HepG2 cells (ABCB1 and ABCG2). Interestingly, although side population (SP) cells isolated from RPMI8226 cells exhibited higher levels of glycolysis with an increased expression of genes involved in the glycolytic pathway, 3BrPA abolished Hoechst 33342 exclusion in SP cells. 3BrPA also disrupted clonogenic capacity in malignant cell lines including RPMI8226, KG-1, and HepG2. Furthermore, 3BrPA restored cytotoxic effects of daunorubicin and doxorubicin on KG-1 and RPMI8226 cells, and markedly suppressed subcutaneous tumor growth in combination with doxorubicin in RPMI8226-implanted mice. These results collectively suggest that the inhibition of glycolysis is able to overcome drug resistance in ABC transporter-expressing malignant cells through the inactivation of ABC transporters and impairment of SP cells with enhanced glycolysis as well as clonogenic cells.
Collapse
Affiliation(s)
- Ayako Nakano
- Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, Tokushima, Japan
| | - Daisuke Tsuji
- Department of Medicinal Biotechnology, Institute for Medicinal Research, University of Tokushima Graduate School of Pharmaceutical Sciences, Tokushima, Japan
| | - Hirokazu Miki
- Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, Tokushima, Japan
| | - Qu Cui
- Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, Tokushima, Japan
| | - Salah Mohamed El Sayed
- Department of Pediatrics, University of Tokushima Graduate School of Medicine, Tokushima, Japan
| | - Akishige Ikegame
- Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, Tokushima, Japan
| | - Asuka Oda
- Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, Tokushima, Japan
| | - Hiroe Amou
- Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, Tokushima, Japan
| | - Shingen Nakamura
- Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, Tokushima, Japan
| | - Takeshi Harada
- Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, Tokushima, Japan
| | - Shiro Fujii
- Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, Tokushima, Japan
| | - Kumiko Kagawa
- Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, Tokushima, Japan
| | - Kyoko Takeuchi
- Division of Transfusion Medicine, Tokushima University Hospital, Tokushima, Japan
| | - Akira Sakai
- Department of Hematology and Oncology, RIRBM, Hiroshima University, Hiroshima, Japan
| | - Shuji Ozaki
- Division of Internal Medicine, Tokushima Prefectural Hospital, Tokushima, Japan
| | - Kazuma Okano
- Department of Medicinal Biotechnology, Institute for Medicinal Research, University of Tokushima Graduate School of Pharmaceutical Sciences, Tokushima, Japan
| | - Takahiro Nakamura
- Department of Medicinal Biotechnology, Institute for Medicinal Research, University of Tokushima Graduate School of Pharmaceutical Sciences, Tokushima, Japan
| | - Kohji Itoh
- Department of Medicinal Biotechnology, Institute for Medicinal Research, University of Tokushima Graduate School of Pharmaceutical Sciences, Tokushima, Japan
| | - Toshio Matsumoto
- Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, Tokushima, Japan
| | - Masahiro Abe
- Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, Tokushima, Japan
- * E-mail:
| |
Collapse
|